Recombinant factor VIIa (rFVIIa) its effective at massive bleeding after caesarean section - A case report

被引:0
|
作者
Sokolic, V
Bukovic, D
Fures, R
Zadro, M
Scuric, I
Colak, F
Celovec, K
Bocan, A
机构
[1] Univ Zagreb, Ctr Hosp, Dept Obstet & Gynecol, Zagreb 10000, Croatia
[2] Gen Hosp Zabok, Dept Anesthesiol & Intens Care Med, Zabok, Croatia
[3] Ctr Hlth Zabok, Zabok, Croatia
关键词
D O I
暂无
中图分类号
Q98 [人类学];
学科分类号
030303 ;
摘要
A case of 31-year old woman who underwent emergency caesarean section (CS) following suspicion of the HELLP syndrome was reported. She developed arterial hypertension in 33(rd) week. In 38(th) week of her gestation elevated liver enzymes and positive albumin in urine were reported and pathological flow in umbilical artery and fetal aorta was found on ultrasound. The HELLP score was 12 and the HELLP syndrome was diagnosed. The pregnancy was terminated by CS for fetal distress and the HELLP syndrome. Two hours after the section she developed massive uterine bleeding with the signs of hemorrhagic shock. Despite of replacement therapy laboratory data worsened. DIC was diagnosed. Recombinant factor VIM was administrated; after several minutes bleeding decreased and laboratory data normalized.
引用
收藏
页码:155 / 157
页数:3
相关论文
共 50 条
  • [21] Recombinant Factor VIIa is an Effective Therapy for Abdominal Surgery and Severe Thrombocytopenia: A Case Report
    Venancio Conesa
    Andrés Navarro-Ruiz
    Joaquín Borrás-Blasco
    Angela Mompel
    Amparo GÓmez
    Mercedes González
    International Journal of Hematology, 2005, 81 : 75 - 76
  • [22] Recombinant factor VIIa is an effective therapy for abdominal surgery and severe thrombocytopenia:: A case report
    Conesa, V
    Navarro-Ruiz, A
    Borrás-Blasco, J
    Mompel, A
    Gómez, A
    González, M
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2005, 81 (01) : 75 - 76
  • [23] Prolonged treatment of massive postpartum haemorrhage with recombinant factor VIIa: case report and review of the literature
    Boehlen, F
    Morales, MA
    Fontana, P
    Ricou, B
    Irion, O
    de Moerloose, P
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2004, 111 (03) : 284 - 287
  • [24] Prophylactic recombinant factor VIIa (rFVIIa) treatment prevented coagulopathy and reduced bleeding in rabbits subjected to vascular injuries
    Kheirabadi, B. S.
    Perez, M. R.
    Cox, A.
    Miranda, N.
    Dubick, M. A.
    Holcomb, J. B.
    SHOCK, 2008, 29 : 119 - 119
  • [25] The evidence for the use of recombinant factor VIIa in massive bleeding: development of a transfusion policy framework
    Moltzan, C. J.
    Anderson, D. A.
    Callum, J.
    Fremes, S.
    Hume, H.
    Mazer, C. D.
    Poon, M. C.
    Rivard, G.
    Rizoli, S.
    Robinson, S.
    TRANSFUSION MEDICINE, 2008, 18 (02) : 112 - 120
  • [26] The evidence for the use of recombinant factor VIIa in massive bleeding: revision of the transfusion policy framework
    Lin, Y.
    Moltzan, C. J.
    Anderson, D. R.
    TRANSFUSION MEDICINE, 2012, 22 (06) : 383 - 394
  • [27] The use of recombinant factor VIIa (rFVIIa) to control bleeding in a neonate with disseminated intravascular coagulation and liver failure.
    Nold, J
    Hargens, L
    Hagen, E
    Moertel, C
    Messinger, Y
    BLOOD, 2003, 102 (11) : 101B - 102B
  • [28] Uterine artery pseudoaneurysm bleeding one decade after caesarean section: A case report
    Johannesson, Liza
    Mason, Jennifer
    Oehler, Martin K.
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2017, 43 (05) : 939 - 942
  • [29] Benefits and risks of recombinant activated factor VII (rFVIIa) in massive bleeding: a single centre study
    Panizo, E.
    Lecumberri, R.
    Rodriguez-Otero, P.
    Hernandez, M.
    Pegenaute, C.
    Paramo, J. A.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 1160 - 1160
  • [30] Guidelines for the use of recombinant activated factor VII (rFVIIa) in uncontrolled bleeding:: a report by the Israeli Multidisciplinary rFVIIa task
    Ariëns, RAS
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2005, 3 (04) : 649 - 650